Monoclonal antibodies reactive with human breast or ovarian carcinoma: In vivo applications

This publication has 78 references indexed in Scilit:

• Neu-Protein Overexpression in Breast Cancer
  New England Journal of Medicine, 1988
• Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients
  Breast Cancer Research and Treatment, 1985
• The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells
  European Journal of Cancer and Clinical Oncology, 1985
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985
• Common Epithelial Cancer of the Ovary
  New England Journal of Medicine, 1985
• Common Epithelial Cancer of the Ovary
  New England Journal of Medicine, 1985
• The use of aIF, AE1, and AE3 monoclonal antibodies for the identification and classification of mammalian epithelial keratins
  Differentiation, 1984
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Monoclonal antibodies applied to primary human breast carcinoma: Relationship to menopausal status, lymph node status, and steroid hormone receptor content
  Breast Cancer Research and Treatment, 1982
• The use of lymphocytes from axillary lymph nodes of mastectomy patients to generate human monoclonal antibodies
  European Journal of Cancer and Clinical Oncology, 1981